Drugs found to both prevent and treat Alzheimer's disease in mice

May 21, 2013

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

The drugs, known as "TSPO ," are currently used for certain types of neuroimaging.

"We looked at the effects of TSPO ligand in young when pathology was at an early stage, and in aged mice when pathology was quite severe," said lead researcher Christian Pike of the USC Davis School of Gerontology. "TSPO ligand reduced measures of pathology and improved behavior at both ages."

The team's findings were published online by the Journal of Neuroscience on May 15. Pike's coauthors include USC postdoctoral scientists Anna M. Barron, Anusha Jayaraman and Joo-Won Lee; as well as Donatella Caruso and Roberto C. Melcangi of the University of Milan and Luis M. Garcia-Segura of the Instituto Cajal in Spain.

The most surprising finding for Pike and his team was the effect of TSPO ligand in the aged mice. Four treatments—once per week over four weeks—in older mice resulted in a significant decrease of Alzheimer's-related symptoms and improvements in memory – meaning that TSPO ligands may actually reverse some elements of Alzheimer's disease.

"Our data suggests the possibility of drugs that can prevent and treat Alzheimer's," Pike said. "It's just mouse data, but extremely encouraging mouse data. There is a strong possibility that TSPO ligands similar to the ones used in our study could be evaluated for in Alzheimer's patients within the next few years."

Next, the team will next focus on understanding how TSPO ligands reduce Alzheimer's . Building on the established knowledge that TSPO ligands can reduce inflammation—shielding from injury and increasing the production of neuroactive hormones in the brain—the team will study which of these actions is the most significant in fighting Alzheimer's disease so they can develop newer TSPO ligands accordingly.

Explore further: Researchers find new target for Alzheimer's drug development

Related Stories

Innovative method to treat Alzheimer's in mice

April 1, 2013

Researchers from the RIKEN Brain Science Institute report that they successfully used a virus vector to restore the expression of a brain protein and improve cognitive functions, in a mouse model of Alzheimer's disease.

Forget about plaque when diagnosing Alzheimer's Disease

April 3, 2013

(Medical Xpress)—An Australian study has shown that plaque, long considered to be the hallmark of Alzheimer's disease, is one of the last events to occur in the Alzheimer's brain. This finding will impact the current debate ...

Scientists develop drug that slows Alzheimer's in mice

May 13, 2013

A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, published May 14 ...

Recommended for you

Predicting change in the Alzheimer's brain

October 6, 2015

MIT researchers are developing a computer system that uses genetic, demographic, and clinical data to help predict the effects of disease on brain anatomy.

Old drug offers new hope to treat Alzheimer's disease

September 21, 2015

Scientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau-related dysfunction in an animal model of frontotemporal dementia (FTD). Salsalate ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.